Morepen Q2 revenue hits record ₹755 Cr, EBITDA up 273%

Morepen Q2 revenue hits record ₹755 Cr, EBITDA up 273% — Morepen Laboratories reported a record Q2 revenue of ₹755 Cr, with EBITDA soaring 273% to ₹132 Cr, driven by strong CDMO momentum. H1 EBITDA reached ₹220 Cr, signaling a major leap in profitability and operational scale. This sharp earnings scale-up reflects robust demand and execution efficiency.

📊 STOCKS: MOREPENLAB | 🏢 SECTOR: Pharma | #HIGHIMPACT #Earnings